Navigation Links
International Isotopes Inc. Names James Mayer as Chief Operating Officer
Date:1/14/2008

IDAHO FALLS, Idaho, Jan. 14 /PRNewswire-FirstCall/ -- International Isotopes Inc. (OTC Bulletin Board: INIS) is pleased to announce the appointment of James Mayer as Chief Operating Officer (COO).

James Mayer joined International Isotopes as Chief Operating Officer on January 11, 2008. Mr. Mayer received his Bachelor of Science in Nuclear Engineering from Texas A & M University and a Masters of Business Administration from the University of Nebraska at Lincoln. He has over 25 years of management experience in the U.S. Navy as well as civilian corporations and he has previously served as Facility Manager, Senior Project Engineer, and Production Manager at a Fortune 500 corporation.

Steve T. Laflin, International Isotopes Inc. President and Chief Executive Officer said, "The Company has not previously had a COO position. However, our rapidly growing manufacturing operations and increasing corporate demands created by additional business opportunities for the Company dictate the need for a dedicated COO. Mr. Mayer has in-depth familiarity with the nuclear industry as well as the commercial sector. He brings with him solid business, management, and operational skills and broad-based experience in manufacturing. He is an outstanding fit to our team and I am certain he will become a valuable asset to the Company as we strive to improve our production efficiencies, reduce operating costs, and incorporate new product lines into the Idaho operations."

About International Isotopes Inc.

International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients.

For more information, visit our website: http://www.intisoid.com

International Isotopes Inc. Safe Harbor Statement

Forward-looking statements in this press release are made pursuant to the safe harbor provision of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change. Actual results may differ materially from the forward-looking statements. Many factors could cause actual results to differ materially from the forward-looking statements. Readers are directed to read the risk factors detailed from time to time in our filings with the Securities and Exchange Commission, including our annual report on Form 10-KSB for the year ending December 31, 2006. The Company does not intend to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

For More Information, Contact:

Steve Laflin, President and CEO

(208) 524-5300


'/>"/>
SOURCE International Isotopes Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. International brain aging expert challenges the existence of Alzheimers as a disease
2. EHE International Supports the American Liver Foundations Efforts at Raising Awareness for Hepatitis
3. QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index
4. International Sports Sciences Associations Ten Best Resolutions for Better Health in 2008
5. Joint Commission International Achieves Accreditation from ISQua
6. International Development Expert to Lead the Pan American Health and Education Foundation
7. Natural Nutrition Launches Long Life Cocktail with International Television Ad Campaign
8. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
9. NEWSWEEK: International Editions: Highlights and Exclusives, Dec. 31, 2007- Jan. 7, 2008
10. Presidential Candidate and Former Arkansas Governor Mike Huckabee to Be Keynote Speaker for Hope International Universitys Celebrate Hope Dinner at Disneyland(R) Hotel
11. AAPD to Present 2008 Henry B. Betts Award to International Human Rights Disability Advocate Eric Rosenthal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps ... in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally ... one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... search for and donate to Give To Cure’s campaign that is crowdfunding clinical trials ... users make and share payments through a smart device. In 2015 alone, Venmo processed ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Dr. Justin ... announce their 2nd Annual No Cost Dental Day to individuals in need. The event ... purpose of this No Cost Dental Day is to provide dental care to community ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... DIEGO, Feb. 4, 2016  Aethlon Medical, Inc. ... affinity biofiltration devices to treat life-threatening diseases, today ... 2016 ended December 31, 2015. ... objectives set forth in our last quarterly call, ... reinforce our long-term objective to establish the Aethlon ...
Breaking Medicine Technology: